Quality of life following chemoradiation and postoperative radiation for locally advanced head and neck cancer.

Sensitivity of salivary glands to radiation: from animal models to therapies. J Dent Res (2009) 1.43

Restoration of radiation therapy-induced salivary gland dysfunction in mice by post therapy IGF-1 administration. BMC Cancer (2010) 1.05

A comprehensive review of head and neck cancer rehabilitation: physical therapy perspectives. Indian J Palliat Care (2012) 0.85

Long-term functional outcomes and patient perspective following altered fractionation radiotherapy with concomitant boost for oropharyngeal cancer. Dysphagia (2012) 0.78

Induction chemotherapy and dose intensification of the radiation boost in locally advanced anal canal carcinoma: final analysis of the randomized UNICANCER ACCORD 03 trial. J Clin Oncol (2012) 2.62

Concurrent or sequential adjuvant letrozole and radiotherapy after conservative surgery for early-stage breast cancer (CO-HO-RT): a phase 2 randomised trial. Lancet Oncol (2010) 1.83

Optimal organ-sparing intensity-modulated radiation therapy (IMRT) regimen for the treatment of locally advanced anal canal carcinoma: a comparison of conventional and IMRT plans. Radiat Oncol (2007) 1.60

Impact of dysphagia on quality of life after treatment of head-and-neck cancer. Int J Radiat Oncol Biol Phys (2005) 1.50

Structure of the DBL3x domain of pregnancy-associated malaria protein VAR2CSA complexed with chondroitin sulfate A. Nat Struct Mol Biol (2008) 1.48

Outcome and prognostic factors in breast sarcoma: a multicenter study from the rare cancer network. Radiother Oncol (2007) 1.47

Aspiration rate following chemoradiation for head and neck cancer: an underreported occurrence. Radiother Oncol (2006) 1.39

Plan comparison of volumetric-modulated arc therapy (RapidArc) and conventional intensity-modulated radiation therapy (IMRT) in anal canal cancer. Radiat Oncol (2010) 1.25

Safety and effectiveness of prophylactic gastrostomy tubes for head and neck cancer patients undergoing chemoradiation. Surg Oncol (2007) 1.24

Combined chemotherapy and radiation therapy for head and neck malignancies: quality of life issues. Cancer (2002) 1.19

MR volumetric measurement of low rectal cancer helps predict tumor response and outcome after combined chemotherapy and radiation therapy. Radiology (2012) 1.18

Differentiating between near- and non-cognate codons in Saccharomyces cerevisiae. PLoS One (2007) 1.17

Breast-conserving therapy for ductal carcinoma in situ of the breast: the French Cancer Centers' experience. Int J Radiat Oncol Biol Phys (2002) 1.16

French multicenter phase III randomized study testing concurrent twice-a-day radiotherapy and cisplatin/5-fluorouracil chemotherapy (BiRCF) in unresectable pharyngeal carcinoma: Results at 2 years (FNCLCC-GORTEC). Int J Radiat Oncol Biol Phys (2006) 1.13

Current concepts in radiation enteritis and implications for future clinical trials. Cancer (2002) 1.03

IORT with electrons as boost strategy during breast conserving therapy in limited stage breast cancer: long term results of an ISIORT pooled analysis. Radiother Oncol (2013) 1.00

Impact of swallowing therapy on aspiration rate following treatment for locally advanced head and neck cancer. Oral Oncol (2006) 0.98

Chronic disseminated candidiasis in patients with acute leukemia: emphasis on diagnostic definition and treatment. Leuk Res (2004) 0.98

Prognostic impact of epidermal growth factor receptor (EGFR) expression on loco-regional recurrence after preoperative radiotherapy in rectal cancer. BMC Cancer (2005) 0.98

Molecular biology of breast cancer stem cells: potential clinical applications. Cancer Treat Rev (2010) 0.97

KRASness and PIK3CAness in patients with advanced colorectal cancer: outcome after treatment with early-phase trials with targeted pathway inhibitors. PLoS One (2012) 0.96

Epidemiologic features and clinical subgroups of anotia/microtia in Texas. Birth Defects Res A Clin Mol Teratol (2009) 0.96

Genetic characterization of the Capra hircus papillomavirus: a novel close-to-root artiodactyl papillomavirus. Virus Res (2006) 0.95

Phase III randomized trial of very accelerated radiation therapy compared with conventional radiation therapy in squamous cell head and neck cancer: a GORTEC trial. J Clin Oncol (2006) 0.94

Concurrent chemoradiation for locally advanced oropharyngeal cancer. Am J Otolaryngol (2006) 0.94

Feasibility of Tomotherapy to spare the cochlea from excessive radiation in head and neck cancer. Oral Oncol (2011) 0.94

IMRT for locally advanced anal cancer: clinical experience of the Montpellier Cancer Center. Radiat Oncol (2012) 0.93

A three-year follow-up report of a comparative study of ITI Dental Implants and Brånemark System implants in the treatment of the partially edentulous maxilla. Clin Implant Dent Relat Res (2004) 0.93

Improved transcutaneous bilirubinometry: comparison of SpectR(X) BiliCheck and Minolta Jaundice Meter JM-102 for estimating total serum bilirubin in a normal newborn population. J Perinatol (2002) 0.93

Antioxidant properties of cerium oxide nanocrystals as a function of nanocrystal diameter and surface coating. ACS Nano (2013) 0.93

Treatment of unresectable, locally advanced pancreatic adenocarcinoma with combined radiochemotherapy with 5-fluorouracil and cisplatin. Pancreas (2002) 0.92

Simplified methods of implant treatment in the edentulous lower jaw: a 3-year follow-up report of a controlled prospective study of one-stage versus two-stage surgery and early loading. Clin Implant Dent Relat Res (2005) 0.91

Dysphagia severity following chemoradiation and postoperative radiation for head and neck cancer. Eur J Radiol (2006) 0.90

Effectiveness of intensity-modulated and image-guided radiotherapy to spare the mandible from excessive radiation. Oral Oncol (2012) 0.89

Functional communication in individuals with chronic severe aphasia using augmentative communication. Augment Altern Commun (2008) 0.89

Effectiveness of image-guided radiotherapy for laryngeal sparing in head and neck cancer. Oral Oncol (2010) 0.88

Impact of tumor board recommendations on treatment outcome for locally advanced head and neck cancer. Oncology (2008) 0.87

Transcriptomic molecular markers for screening human colon cancer in stool and tissue. Cancer Genomics Proteomics (2007) 0.86

Aspiration occurence during chemoradiation for head and neck cancer. Anticancer Res (2007) 0.86

Feasibility of intensity-modulated and image-guided radiotherapy for functional organ preservation in locally advanced laryngeal cancer. PLoS One (2012) 0.85

Immediately loaded implants supporting fixed prostheses in the edentulous maxilla: a preliminary clinical and radiologic report. Int J Oral Maxillofac Implants (2005) 0.85

Feasibility of tomotherapy for Graves' ophthalmopathy: Dosimetry comparison with conventional radiotherapy. Strahlenther Onkol (2011) 0.85

Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer. Gynecol Oncol (2005) 0.84

Prevalence of pharyngeal and esophageal stenosis following radiation for head and neck cancer. J Otolaryngol Head Neck Surg (2008) 0.84

Feasibility of tomotherapy to reduce normal lung and cardiac toxicity for distal esophageal cancer compared to three-dimensional radiotherapy. Radiother Oncol (2011) 0.84

Aspiration rate following nonsurgical therapy for laryngeal cancer. ORL J Otorhinolaryngol Relat Spec (2006) 0.84

Pro- and anti-inflammatory substances modulate expression of the leukotriene B4 receptor, BLT1, in human monocytes. J Leukoc Biol (2005) 0.84

Severity and duration of chronic dysphagia following treatment for head and neck cancer. Anticancer Res (2005) 0.84

Effectiveness of prophylactic retropharyngeal lymph node irradiation in patients with locally advanced head and neck cancer. BMC Cancer (2012) 0.84